Elm Partners Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.61M Sell
3,843
-34
-0.9% -$34.7K 0.17% 40
2026
Q1
$3.44M Buy
3,877
+40
+1% +$40.6K 0.15% 40
2025
Q4
$4.12M Sell
3,837
-64
-2% -$61.2K 0.19% 37
2025
Q3
$2.98M Buy
3,901
+290
+8% +$216K 0.15% 42
2025
Q2
$2.81M Buy
+3,611
New +$2.81M 0.16% 35

Other funds holding LLY

Elm Partners Management's LLY Position: Q2 2026 in Review

Elm Partners Management reduced its Eli Lilly (LLY) stake by 0.88% in Q2 2026, selling an estimated $34.7K and leaving 3,843 shares worth $4.61M. The position accounts for 0.17% of the portfolio, ranked #40.

Elm Partners Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Elm Partners Management held 3,843 shares of Eli Lilly worth $4.61M as of Q2 2026.
  • Elm Partners Management sold 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
  • Eli Lilly made up 0.17% of Elm Partners Management's portfolio in Q2 2026, its #40 holding.
  • Elm Partners Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Elm Partners Management's 13F filing for Q2 2026, filed 28 Jul 2026.